publication date: Jul. 5, 2019

Clinical Roundup

Cancer cost $94.4 billion in lost earnings and 8.7 million years of life in 2015

Cancer took more than 8.7 million years of life and $94.4 billion in lost earnings among people ages 16 to 84 in the United States in 2015. The calculation comes from a new report by American Cancer Society researchers that appears early online in JAMA Oncology.

Accurate information on the economic burden of cancer mortality can help in setting policies and prioritizing resources for cancer prevention and control. However, contemporary data are lacking for the United States nationally and by state.

To update estimated lost earnings due to death from cancer, investigators led by Farhad Islami, calculated person-years of life lost using numbers of cancer deaths and life expectancy data in individuals aged 16 to 84 years who died from cancer in the U.S. in 2015.

They created estimates for cancer deaths overall and for the major cancers in the U.S. nationally and by state. The estimates are for lost earnings alone, and do not include other costs associated with cancer, including costs of treatment and caregiving.

A total of 492,146 cancer deaths occurred in people ages 16 to 84 in the U.S. in 2015, translating to a total of 8,739,939 life years lost. Overall lost earnings were $94.4 billion, and $191,900 per cancer death. Lost earnings were $29.0 million per 100,000 population overall.

Lung cancer cost the most in lost earnings ($21.3 billion; 22.5% of total), followed by colorectal ($9.4 billion; 10.0%), female breast ($6.2 billion; 6.5%), and pancreatic ($6.1 billion; 6.5%) cancers. By age, lost earnings were highest for leukemia in ages 16 to 39 while lung … Continue reading Cancer cost $94.4 billion in lost earnings and 8.7 million years of life in 2015

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.